Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.
国际肺癌研究协会的官方期刊《胸部肿瘤学杂志》（JTO）是所有胸部恶性肿瘤的预防、检测、诊断和治疗相关主题的主要教育和信息出版物。JTO强调多学科方法，包括原创研究评论和意见文章。听众包括流行病学家、医学肿瘤学家、放射肿瘤学家、胸外科医生、肺病学家、放射科医生、病理学家、核医学医生和对胸部肿瘤学有特殊兴趣的研究科学家。
24‐Month Overall Survival from KEYNOTE‐021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First‐Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.08.004
Third‐Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.003
Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One‐Year Results of the Prospective, Multicenter NAVIGATE Study
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.11.013
A Randomized Non‐Comparative Phase II Study of Anti‐Programmed Cell Death‐Ligand 1 Atezolizumab or Chemotherapy as Second‐Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT‐1603 Trial
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.01.008
Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)‐Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.005
Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR‐Mutated Advanced NSCLC
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.150
Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.002
Pseudoprogression in Previously Treated Patients with Non–Small Cell Lung Cancer Who Received Nivolumab Monotherapy
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.167
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non–Small Cell Lung Cancer
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.001
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR‐Mutated Lung Cancers
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.12.038
Correlation of PD‐L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early‐Stage Squamous Cell Lung Carcinoma
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.006
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.08.2028
DNA‐Based versus RNA‐Based Detection of MET Exon 14 Skipping Events in Lung Cancer
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.12.020
Osimertinib versus Standard of Care EGFR TKI as First‐Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.004
Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.026
OA14.02 IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.484
Evaluation of the Prognostic Significance of TNM Staging Guidelines in Lung Carcinoid Tumors
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.166
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.12.021
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First‐Line Therapy in Patients with Extensive‐Disease Small Cell Lung Cancer
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.01.010
Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.008
Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.01.019
ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.12.001
Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.025
Procedure‐Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.008
Neoadjuvant Crizotinib in Resectable Locally Advanced Non–Small Cell Lung Cancer with ALK Rearrangement
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.161
The Unique Spatial‐Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.11.020
Health‐Related Quality of Life in KEYNOTE‐010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.01.016
2017–2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.01.022
Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.10.007
Efficacy of Alectinib in Patients with ALK‐Positive NSCLC and Symptomatic or Large CNS Metastases
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.12.002
Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.01.024
A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce
来源期刊：Journal of Thoracic OncologyDOI：10.1016/J.JTHO.2019.04.029
Alcohol Intake Interacts with Functional Genetic Polymorphisms of Aldehyde Dehydrogenase (ALDH2) and Alcohol Dehydrogenase (ADH) to Increase Esophageal Squamous Cell Cancer Risk
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.12.023
Adjuvant Systemic Therapy in Patients With Early‐Stage NSCLC Treated With Stereotactic Body Radiation Therapy
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.11.018
Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.01.002
Positron‐Emission Tomography Scan–Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron‐Emission Tomography Nonresponders
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.152
Disparities in the Diagnosis and Treatment of Lung Cancer among People with Disabilities
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.158
Association of PALB2 Messenger RNA Expression with Platinum‐Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.168
A Population‐Based Study of Outcomes in Surgically Resected T3N0 Non–Small Cell Lung Cancer in The Netherlands, Defined Using TNM‐7 and TNM‐8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.164
Prophylactic Cranial Irradiation for Limited‐Stage Small‐Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.09.019
Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.10.005
Antibody‐Drug Conjugates for the Therapy of Thoracic Malignancies
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2018.11.034
MA14.05 A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.613
PCI for Radically Treated Non-Small Cell Lung Cancer: A Meta-Analysis Using Updated Individual Patient Data of Randomized Trials
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.471
P2.17-05 Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.1916
Lung Cancer Occurrence Attributable to Passive Smoking Among Never Smokers in China : A Systematic Review and Meta-Analysis
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.1700
YI03.03 Scientific Mentorship: What Should You Expect?
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.2497
PD01.11 Artificial Intelligence Can Detect Lung Cancer From High Resolution Microscopic Images of Conditioned Peripheral Blood
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.09.049
P1.16-38 Racial Disparities in Long-Term Survival After Surgical Resection in the US
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.1264
Circulating miRNA : a biomarker for classification of lung cancer and benign lung disease
来源期刊：Journal of Thoracic OncologyDOI：10.1016/j.jtho.2019.08.624
